1. |
Huang, W.; Han, N.; Du, L.; Wang, M.; Chen, L.; Tang, H. A narrative review of liver regeneration-from models to molecular basis. Ann Transl Med. 2021, 9, 1705.
doi: 10.21037/atm-21-5234
pmid: 34988214
|
2. |
Qian, Y.; Shang, Z.; Gao, Y.; Wu, H.; Kong, X. Liver regeneration in chronic liver injuries: basic and clinical applications focusing on macrophages and natural killer cells. Cell Mol Gastroenterol Hepatol. 2022, 14, 971–981.
doi: 10.1016/j.jcmgh.2022.05.014
pmid: 35738473
|
3. |
Xu, Z.; Jiang, N.; Xiao, Y.; Yuan, K.; Wang, Z. The role of gut microbiota in liver regeneration. Front Immunol. 2022, 13, 1003376.
|
4. |
Li, Y.; Lu, L.; Cai, X. Liver regeneration and cell transplantation for end-stage liver disease. Biomolecules. 2021, 11, 1907.
|
5. |
Liu, Y.; Sheng, J. Y.; Yang, C. F.; Ding, J.; Chan, Y. S. A decade of liver organoids: Advances in disease modeling. Clin Mol Hepatol. 2023, 29, 643–669.
|
6. |
He, C.; Lu, D.; Lin, Z.; Chen, H.; Li, H.; Yang, X.; Yang, M.; Wang, K.; Wei, X.; Zheng, S.; Xu, X. Liver organoids, novel and promising modalities for exploring and repairing liver injury. Stem Cell Rev Rep. 2023, 19, 345–357.
|
7. |
Wang, L.; Li, M.; Yu, B.; Shi, S.; Liu, J.; Zhang, R.; Ayada, I.; Verstegen, M. M. A.; van der Laan, L. J. W.; Peppelenbosch, M. P.; Cao, W.; Pan, Q. Recapitulating lipid accumulation and related metabolic dysregulation in human liver-derived organoids. J Mol Med (Berl). 2022, 100, 471–484.
doi: 10.1007/s00109-021-02176-x
pmid: 35059746
|
8. |
Sun, X. C.; Kong, D. F.; Zhao, J.; Faber, K. N.; Xia, Q.; He, K. Liver organoids: established tools for disease modeling and drug development. Hepatol Commun. 2023, 7, e0105
|
9. |
Lee, J.; Mun, S. J.; Shin, Y.; Lee, S.; Son, M. J. Advances in liver organoids: model systems for liver disease. Arch Pharm Res. 2022, 45, 390–400.
|
10. |
Mun, S. J.; Hong, Y. H.; Shin, Y.; Lee, J.; Cho, H. S.; Kim, D. S.; Chung, K. S.; Son, M. J. Efficient and reproducible generation of human induced pluripotent stem cell-derived expandable liver organoids for disease modeling. Sci Rep. 2023, 13, 22935.
|
11. |
Liu, Q.; Wang, S.; Fu, J.; Chen, Y.; Xu, J.; Wei, W.; Song, H.; Zhao, X.; Wang, H. Liver regeneration after injury: Mechanisms, cellular interactions and therapeutic innovations. Clin Transl Med. 2024, 14, e1812
|
12. |
Starlinger, P.; Brunnthaler, L.; McCabe, C.; Pereyra, D.; Santol, J.; Steadman, J.; Hackl, M.; Skalicky, S.; Hackl, H.; Gronauer, R.; O’Brien, D.; Kain, R.; Hirsova, P.; Gores, G. J.; Wang, C.; Gruenberger, T.; Smoot, R. L.; Assinger, A. Transcriptomic landscapes of effective and failed liver regeneration in humans. JHEP Rep. 2023, 5, 100683.
|
13. |
Liu, X.; Khalafalla, M.; Chung, C.; Gindin, Y.; Hubchak, S.; LeCuyer, B.; Kriegermeier, A.; Zhang, D.; Qiu, W.; Ding, X.; Fang, D.; Green, R. Hepatic deletion of X-box binding protein 1 in FXR null mice leads to enhanced liver injury. J Lipid Res. 2022, 63, 100289.
|
14. |
Liu, H. M.; Chang, Z. Y.; Yang, C. W.; Chang, H. H.; Lee, T. Y. Farnesoid X receptor agonist GW4064 protects lipopolysaccharide-induced intestinal epithelial barrier function and colorectal tumorigenesis signaling through the αKlotho/βKlotho/FGFs pathways in mice. Int J Mol Sci. 2023, 24, 16932.
|
15. |
Jiang, S.; Xu, F.; Jin, M.; Wang, Z.; Xu, X.; Zhou, Y.; Wang, J.; Gu, L.; Fan, H.; Fan, Y.; Zhou, Z.; Li, C.; Chen, P. Development of a high-throughput micropatterned agarose scaffold for consistent and reproducible hPSC-derived liver organoids. Biofabrication. 2022, 15, 015006.
|